Henry Schein, Inc. has announced the acquisition of Veterinary Instrumentation, the supplier of surgical instruments and implants to veterinary surgeons in the United Kingdom.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein said: "We are delighted to welcome this highly regarded company to the Henry Schein family, and very pleased that founder John Lapish and Managing Director Steve Fletcher will continue to drive the business forward.
"The success of Veterinary Instrumentation closely parallels the cornerstones of Henry Schein, including a deep understanding of customer needs, innovative solutions, superior product quality and customer service, and a trusted advisory relationship with our customers. Reinforcing our existing animal health business in the U.K., we look forward to strengthening our relationship with veterinary customers in this region, and bringing the Veterinary Instrumentation product portfolio of high-quality surgical specialties to a growing number of veterinarians across Europe, the United States and Australasia."
Veterinary Instrumentation was founded by John Lapish in 1986 in Sheffield, England, where the business and distribution operations are currently conducted from a single facility. Working as a small animal orthopaedic surgeon in the late 1970s, Mr. Lapish began designing and developing a range of instruments specifically for veterinary surgery, initially for his own use. As requests for these products increased, the market need became clear and Veterinary Instrumentation was formed, in particular to meet the needs of orthopaedic surgeons focused on small animals.
Mr Lapish said: "We look forward to contributing to the continued growth and success of a leading supplier of companion animal health products and services in the United Kingdom and to becoming part of a global leader in the distribution of health care products and services.
"The expertise that we bring in the area of veterinary surgical instruments will complement Henry Schein's broad offering, and our customers will benefit greatly from the global resources of a company that has quickly become an animal health care product and service leader on three continents."
With approximately 60 percent of sales in the U.K., and the balance split fairly evenly between Europe and the rest of the world, Veterinary Instrumentation has 20 employees, including a team of eight Veterinary Technicians who advise customers on the most appropriate procedures and instrumentation.
Veterinary Instrumentation sales for the 12 months ended September 30, 2011 were approximately £6.7 million ($10.8 million). Financial terms of the transaction were not disclosed.
Ceva Animal Health, manufacturer of Feliway and Adaptil, is making a last call for nominations for its awards for animal welfare, which must be received by 27th January 2012.
The inaugural awards, which take place during WSAVA/BSAVA/FECAVA Congress in Birmingham in April, formally recognise veterinary professionals and individuals who have gone the extra mile to improve animal welfare both in practice and beyond. The awards feature three categories:
Prizes include a trip to New Zealand WSAVA in 2013 for the winner of the Chris Laurence Vet of the Year Award, a trip to a European Animal Welfare Congress for the winner of the Welfare Nurse of the Year Award and £1,000 worth of travel vouchers for the winner of the Pet Lover's Welfare Award.
Nomination forms can be downloaded from www.ceva.co.uk. Nominations should consist of full details about why the nominee deserves to win. Judging will be based on support materials such as case studies, examples and pictures, demonstrating the nominee's commitment to animal welfare. Anyone, whether a veterinary professional, pet owner or animal lover can nominate. All those who have nominated someone for an award will be entered into a prize draw to win £250 of high street vouchers.
For further information, telephone Ceva Animal Health on 01494 781510, email welfare.awards@ceva.com or contact your local Ceva territory manager.
The 2012 edition of the NOAH Compendium of Data Sheets for Animal Medicines has been published and a free copy sent to each veterinary practice in the UK.
This edition has a redesigned cover, developed for NOAH's 25th anniversary which took place this year. It contains data sheets from 32 companies which can be accessed through colour-coded indexes. The book also includes the up-to-date edition of NOAH's Code of Practice for the Promotion of Animal Medicines.
NOAH chief executive Phil Sketchley said: "This book - along with the online version - is a major part of NOAH's efforts to help provide prescribers and users of animal medicines with information to assist the appropriate and responsible use of all animal medicines."
He urged prescribers not to forget the back-up that company advisors can give to assist a prescribing decision: "The compendium also includes another vital resource - the contact details for each company. Company veterinary and technical advisors have detailed knowledge about their company's medicines at their fingertips. They are ready to talk to prescribers about the use of a medicine in a particular animal or in a particular situation, as well as to explain any queries about the data sheet," he said.
If your practice has not received its copy, contact Ruth Herbert at NOAH (r.herbert@noah.co.uk).
Extra copies are also available to order now, for £42. There are special prices for bulk orders.
Hill's Pet Nutrition has reported some early results from its '60 Tonnes in 6 Months' pet weight loss campaign, which started 2 months ago.
The company says that although there is only preliminary data available from 33 practices, it's clear that the campaign is working, with each practice involved reporting on average over 10 Kg weight loss from their patients. However, many practices are holding on to send in results until their patients have reached their final targets, so more data is expected.
Hill's says that some practices have had great success using its PR kit, generating positive coverage in local newspapers. Sara Locke, Associate Customer Marketing Manager is reminding practices that January is the traditional time for 'dieting fever' to hit the headlines after the indulgencies of the festive season. She said: "If you have one of our PR kits, don't forget to send out your pro forma press release - it's not a big task to customise it with your practice details and you could find yourself making a big splash locally at a time when we know interest will be heightened."
As part of the campaign, Hill's has also produced a series of nurse webinars, the last of which was on exercise and rehabilitation programmes for overweight pets and contains tips on how to develop a personalised exercise programme that fits with the owner's lifestyle and reflects the pet's capabilities and level of mobility. The webinar can be viewed here: https://hillsvet.webex.com/hillsvet/lsr.php?AT=pb&SP=EC&rID=13881732&rKey=E1182C100CB53476
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
The Libel Reform Campaign is asking supporters to lobby their MP to make sure that a reform of libel law gets into next year's Queen's Speech, which sets the legislative agenda for 2012.
Two cases in particular serve to highlight the impact of current law on the open discussion of medical science, that of the British Chiropractic Association vs Simon Singh (the author and Guardian journalist) and Matthaias Rath, a vitamin pill manufacturer vs Ben Goldacre (also an author and Guardian journalist).
The proposed new law will, amongst other things, help safeguard free and robust debate about veterinary science, so I urge you to lobby your MP. You can do that by clicking here.
The RSPCA has released details of the more eccentric calls made to the charity over the course of 2011.
Doubtless members of VetSurgeon.org and VetNurse.co.uk will empathise with the RSPCA over some of these, but do you have any better examples? If so, please email them to support@vetsurgeon.org.
Elanco Companion Animal Health - maker of Comfortis, the flea treatment for dogs - is hosting an online evening webinar on Tuesday 10th January to highlight what pet owners want from their vets.
The free webinar follows research into the perceptions of clients and veterinary surgeons as to what attributes constitute a 'good vet'1. According to Elanco, the research revealed a distinct mismatch between what vets think and what pet owners think. The webinar will highlight these differences and the steps veterinary professionals can take to address them. Additionally, it will provide veterinary professionals with the opportunity to learn more about Comfortis and ask questions of Elanco's technical consultants.
Presented by Alan Robinson BVSc MRCVS DMS, a business development consultant for independent veterinary practices, the webinar will start at 8.00pm and will account for two hours CPD. Veterinary surgeons and nurses wishing to book a place should visit www.thewebinarvet.com/comfortis.
For further information, please telephone 01256 353131, email elancoCAH.uk@lilly.com or contact your local Elanco key account manager.
Royal Canin has launched two new skincare diets.
'Hypoallergenic Wet' is a wet adaptation of its 'Hypoallergenic' range of diets, providing variety for the nutritional management of dogs with adverse food reactions. 'Anallergenic' dry food is for the dietary management of dogs with even the most severe dietary allergy.
'Hypoallergenic Wet' contains soy protein hydrolysate, so it can either be fed as a complete diet or interchanged and used as an addition to Hypoallergenic, Hypoallergenic Moderate Calorie or Hypoallergenic Small Dog. The wet food, available in a 400g can, can be recommended for short term feeding (for an elimination diet strategy) or for the lifelong nutritional management of dogs with adverse food reactions. Royal Canin says it is designed to be highly digestible through its low molecular weight peptides and is also appropriate for the dietary support of dogs with inflammatory bowel disease, chronic diarrhoea and Exocrine Pancreatic Insufficiency (EPI).
'Anallergenic' follows in the footsteps of Hypoallergenic but goes further - offering both hydrolysed proteins and a pure carbohydrate source, to which exposure is limited and therefore allergy would be rare. The diet comprises a unique protein source composed exclusively of free amino acids and very low molecular weight oligopeptides. Much like the Hypoallergenic range, Anallergenic is also formulated with essential fatty acids to help support skin health and a complex of nutrients to help maintain the barrier effect of the skin.
The fully balanced diet - suitable for the nutritional support of adult dogs either short or long-term - has proven results with 100% of dogs in a Royal Canin study showing significant improvement in their skin condition.
Gudi Stuttard BVSc MRCVS, one of Royal Canin's Veterinary Support Managers, said: "These two new products join our well-established 'Hypoallergenic' range, as well as our recently launched 'Skin Care' diets - for the nutritional management of dogs with dermatosis unrelated to food intolerance or allergy.
"By building on our portfolio of veterinary skin care diets, we aim to further strengthen our DermAlliance campaign, which is dedicated to assisting in the improvement of skin care knowledge in general veterinary practice."
Please visit www.royalcanin.co.uk for more information.
The British Veterinary Association's Animal Welfare Foundation has produced an online advice leaflet to guide veterinary surgeons through the possible scenarios in the consulting room.
'The practical and legal approach to the docked puppy' leaflet answers questions like:
Introducing the leaflet BVA AWF Chair Tiffany Hemming said: "With such complex and varying laws on tail docking of dogs this leaflet provides clear guidance for vets on how to handle the first consultation with a docked puppy.
"The leaflet includes an easy to follow flow-chart and aims to help vets tackle the subject without alienating their clients."
You can view the leaflet here.
Pedigree has announced that it has raised over £160,000 to help the thousands of dogs abandoned every year in the UK, through its charitable initiative, The Pedigree Adoption Drive 2011.
Pedigree says its fundraising comes at a crucial time, as rescue centres' facilities across the country are severely suffering under the strain of the highest level of dog abandonment in over a decade.
The Pedigree Adoption Drive, which launched in mid-October, aims to raise awareness of the ever-increasing issues of dog abandonment and funds for the hundreds of rescue centres across the country that work tirelessly to find these dogs new loving homes.
Now in its fourth year, the campaign called upon dog lovers everywhere to show their support, by taking part in the world's first virtual dog walk around the web. In addition, consumers got involved in a host of other activities - donating via text message and online, to help the Drive reach this year's grant total.
The funds raised this year will be distributed through grants to 90 rescue homes across the country - including three special grants of £15,000 given to Bath Cats and Dogs Home, £20,000 given to North Clwyd Animal Rescue and £25,000 given Birmingham Dogs Home. Every grant will be put towards projects aimed at making tomorrow better than today for dogs - including the refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and vet Steve Leonard, who is the ambassador of this year's campaign, said: "The money raised from this year's Pedigree Adoption Drive is a great example of how we can achieve so much together to help take steps towards tackling the issue of dog abandonment. The grants awarded to rescue centres this year will make a big difference in helping to find many rescue dogs, the loving homes they deserve."
Katie Wragg, Pedigree Adoption Drive Brand Manager said: "In the last four year's we've raised over £1million for rescue centres supporting the country's abandoned dogs and despite the tough economic climate, the amazing public reaction has enabled us to really make a difference to the lives of abandoned dogs across the UK and help give them a bright future."
For more information on the campaign log on to: http://www.pedigreeadoptiondrive.com/
A man who worked as a veterinary surgeon in Wiltshire, despite being neither qualified nor registered with RCVS, has received a 20-month sentence at Swindon Crown Court.
Peter Keniry (also known as Patrick Keniry), from Great Yarmouth, had been practising under the name of a properly qualified and legitimately registered veterinary surgeon, and was arrested on 23 August. At his initial hearing in Swindon Magistrates' Court, Mr Keniry pleaded guilty to charges of fraud by misrepresentation and unlawfully practising as a veterinary surgeon, and was released on bail.
At the Crown Court on Friday, Mr Keniry also pleaded guilty to additional charges before being sentenced. It is understood he will serve a number of months in prison, before being released on licence for the remaining period.
The RCVS assisted Wiltshire police in their apprehension of Keniry in August, having been alerted the previous day to his fraudulent activities. Mr Keniry is no stranger to the College or the police, having already been dealt with in 1998, 2001 and 2005 for similar offences. On each occasion, Mr Keniry has impersonated a member of the College whose name is legitimately on the Register, which makes it difficult even for practices that do check the credentials of prospective employees to pick up a problem.
Commenting on the recent sentencing, Gordon Hockey, RCVS Head of Professional Conduct said: "We are satisfied that the Court has clearly recognised the risk posed to both animal welfare and public safety by bogus veterinary surgeons. Anyone working as a veterinary surgeon when not qualified to do so, risks a custodial sentence.
"Mr Keniry's continued pattern of re-offending shows him to be a very convincing fraudster. By publicising his photograph, we hope to help any potential employer or locum agency reduce the chances of this happening again," he added.
A research project funded by The Horse Trust has found that various types of ocular tumours can be successfully treated with mitomycin C, a cytotoxic antibiotic isolated from a bacterium.
The research concludes that mitomycin C offers a safe and cost effective alternative to current treatment options such as surgery and radiation.
The research project was led by Fernando Malalana, while working as The Horse Trust's Clinical Scholar in Equine Internal Medicine at University of Liverpool. Fernando is now working as a Clinician Teacher in Equine Internal Medicine at the university.
Ocular tumours are more difficult to treat than tumours in other parts of the horse's body due to the risk of damaging the eye. In the study, Malalana investigated the use of mitomycin C in treating ocular squamous cell carcinoma, the most common ocular tumour in horses, and occular sarcoids, skin tumors that frequently affect the eyelids .
Mitomycin C is an antibiotic isolated from a bacterium, Streptomyces caespitosus. It is known to have cytotoxic effects and has been used to treat tumours in horses before, but only in combination with surgery.
Currently, the main method of treating ocular squamous cell carcinoma is by removing the tumour surgically or with radiation. Both treatments are costly and have a number of associated risks. There is also the risk of damage or scarring to the eye.
Fourteen horses with ocular squamous cell carcinoma, three of which were affected bilaterally, were included in the study. Mitomycin C was applied to the conjunctival sac of the affected eye; in some of the cases the treatment was combined with surgery. Malalana found that of the 8 eyes treated with mitomycin C alone, clinical resolution occurred in 6 cases. Of the 9 eyes treated with both surgery and mitomycin C, clinical resolution occurred in 7 cases.
Mitomycin C was also used to treat various types of sarcoids found in the eye. Currently, the most effective treatment for occular sarcoids is radioactive wire. However, radioactive wire treatment is not ideal as it is expensive, only offered in two locations in the UK, and has potential health risks to the vet applying the wire due to exposure to radioactivity.
Six horses and two donkeys with occular sarcoids, including one horse that was affected bilaterally, were treated with mitomycin C, which was injected directly into the tumour. Malalana found that of the nine nodular and fibroplastic occular sarcoids treated with the antibiotic, all were completely cleared. However, the vets did not have good results with verrucous sarcoids.
Malalana said: "The results of this research should offer hope to the owners of horses that have eye tumours. We have already been contacted by vets from across Europe to find out more information about this treatment and hope that it will be offered to more horses with occular tumours in the future".
Vets at the University of Liverpool are now testing the use of mitomycin C on other tumours that are difficult to treat surgically, including melanomas near the horse's anus. So far, two cases have been treated, but it is too early to tell whether treatment has been successful.
Malalana's research has been submitted to Veterinary Ophthalmology journal.
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
Companion Care Vets has opened its first new standalone joint venture surgery in Ayr, Scotland.
At 3,071 sq ft the £300,000 surgery is the largest of the groups' 86 strong network and is the first standalone surgery to be opened under the joint venture partnership model that has been in place since 2001.
The surgery is located in a retail park environment, to give easy access for clients and their pets. It is a full service practice, which Companion Care says is fitted with all the latest equipment, including digital x-ray machines and a full operating suite.
Managing Director, Jane Balmain, said: "The opening of our first new standalone surgery in Ayr is a real milestone for us as a business because it opens up our offering to the vets and veterinary nurses who are interested in a joint venture partnership, but whose preference is to have a more traditional looking standalone surgery."
Whilst the Ayr surgery is standalone in its own right, due to the unique relationship Companion Care Vets has with Pets at Home, the surgery works in close partnership with the local Pets at Home store. This will help to drive client registrations and business development and further enable Pets at Home to develop the full pet care experience for its customers.
Jane added: "We believe that this new venture offers any potential partner the best of both worlds: a superb in-store surgery with footfall of thousands of customers a month, or a standalone new surgery linked to local store network to develop the business. I don't believe any other company can offer this unique proposition."
Veterinary surgeon, and joint venture partner of the Ayr surgery, Kirstin Fyfe says, "I am extremely proud to be opening the first standalone surgery alongside the Companion Care team and the facilities available to my team and I and local pet owners are fantastic. The latest equipment, coupled with a spacious and modern waiting area and the convenience of our location is what makes this a winning formula."
The Royal College of Veterinary Surgeons has produced bookmarks for accredited practices to give clients, which explain the RCVS Practice Standards Scheme (PSS).
Lizzie Lockett, Head of the RCVS Communications Department said: "A key part of the PSS is helping practices explain their accreditation to clients - and the bookmarks are a simple and eye-catching promotional tool for this. We hope they will have the advantage over conventional leaflets of being kept, and used, by clients, meaning the accredited-practice message is more likely to be taken on board. Although many people are using e-books these days, the traditional book - and bookmark - still has a place."
All accredited practices may order a free sample of 100 bookmarks, and a further 400 free bookmarks are available to practices recently renewing or receiving accreditation. More bookmarks may also be ordered from the RCVS, as well as the new accredited-practice logos. To find out more, or download an order form, practices can visit www.rcvs.org.uk/PSSpromo.
Animalcare has been found in breach of Clause 18.2 of the NOAH Code of Practice for offering and supplying infusion pumps/equipment in exchange for veterinary practices entering into written contracts for the purchase of a range of its products, including the POM-V Benazecare.
The value of the equipment offered by Animalcare equated with a discount agreed with the veterinary practice, and was applied as medicinal products were purchased. The equipment was supplied on the signing of a contract. The terms of the contract required a particular quantity of medicinal products to be purchased, and if the veterinary practice failed to meet that requirement, there was a liability to pay a pro-rata element of the equipment purchase price.
The Code of Practice Committee was of the view that a piece of equipment was neither 'price' nor 'product' within the meaning of Clause 18.2 of the Code of Practice; and as such amounted to a gift being offered in relation to the sale; or purchase; or prescription of animal medicine. The Committee took into account that Guidance Note 4, paragraph 7, states that the word "gift" includes any pecuniary advantage being offered, with the exception of price or product itself.
To comply with Code of Practice Clause 18.2, the offer or inducement based on price had to be one of cash as rebated discount. If then there were facilities to enable the veterinary practice to use that rebated discount to purchase the equipment from the supplier, that might be acceptable, but there was a necessity for cash as rebated discount to be provided in the first instance.
Full details of the Committee's rulings are available on the NOAH website at www.noah.co.uk/code.
Norbrook Laboratories has launched NoroQuin, a nutritional glucosamine-based supplement which the company claims will help maintain healthy cartilage and joint fluids in cats, dogs and horses.
The NoroQuin range has six active ingredients including glucosamine, chondroitin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine which combine to maintain glycosaminoglycans (GAGs) levels in joints and, according to Norbrook, ease and reduce the onset of joint damage and cartilage degeneration.
Michelle Jones, Norbrook Brand Manager, said: "Our new NoroQuin range is an exciting new development to our joint-management range.
"NoroQuin offers more ingredients than the competition with 6 active ingredients working together to help improve mobility. The main ingredient, glucosamine stimulates natural repair and prevents cartilage degeneration and thinning while it is widely considered that glucosamine and chondroitin sulphate have anti-inflammatory properties, making Noroquin ideal for assisting with pain management. The addition of manganese sulphate helps stimulate natural cartilage repair."
NoroQuin is available in a range of meat flavoured tablet sizes that have been formulated to treat all dogs from growing puppies to the largest dogs. For cats, the range is available in a tablet form or as a powder which can be added to a cat's food.
NoroQuin for dogs and cats is available to order from wholesalers now.
Vetoquinol has announced that the 50g pack size of Ipakitine will shortly be replaced by a 60g pot.
The company says this will provide the convenience of a 30 day supply for a 5kg cat or dog who is on 1g/5kg bodyweight twice a day (one level scoop twice a day).
The 60g pot will be available from the end of December. Also at this time, the existing 150g size pot will be replaced by a 180g pot.
The new packaging is more eye-catching, easier to read and gives more description. A 300g pot will also be available in February 2012. Pricing will be in-line with increase in pack size, so proportionally a 20% increase for 20% more product.
Ipakitine is a phosphate binder formulated specifically for veterinary use. It is designed for both cats and dogs and is available as a tasteless powder formulation for easy administration with food.
The London Vet Show was a runaway success this year, with more delegates on day one than visited the entire show in 2010.
Rob Chapman from CloserStill Media, organiser of the event said: "We're still number crunching, but it looks like numbers were up something like 40% on last year."
VetSurgeon.org visited the event and filmed a number of the commercial exhibitors, many of whom said what a good atmosphere there was at the show and how busy it was.
CloserStill has already confirmed that the London Vet Show will again take place in the Grand Hall at London Olympia next year. However, it will be expanding into West Hall for the clinical lectures, so that everyone can have a seat, unlike this year when demand was so high, some had to sit on the floor.
The BSAVA has announced a partnership with the University of Liverpool to develop a national UK disease surveillance network for companion animals.
Originally established in 2008, the Small Animal Veterinary Surveillance Network, SAVSNET, aimed to monitor the disease status of the UK small animal population (mainly dog, cat and rabbit). However, funding for the project came to an end in August 2011. At this point, BSAVA stepped in with support, as it believed that not only would the profession benefit from this source of information, but that it is in fact vital for the successful management of disease in small animals.
BSAVA President Andrew Ash said: "SAVSNET ticks all the boxes for BSAVA. High quality large scale epidemiological research helps us fulfil our obligations as a charity to public good, the information on disease surveillance gives us the information to treat animals better, and the research papers help us inform veterinary policy and education. This is an important scheme for both animal and human health."
Participation by diagnostic labs and practices is voluntary, and all data gained will be made anonymous before being reported. For more information, email savsnet@liverpool.ac.uk.
Dunlops has changed its name to Henry Schein Animal Health.
David Hinton, Managing Director said: "As we change our name to Henry Schein Animal Health, we also reaffirm our company's strong commitment to offer a comprehensive array of products and services to help animal health practitioners in the United Kingdom operate more efficient and successful practices, and provide the best quality patient care.
"We have a new name, but we have the same strong team, the same values, and the same dedication to providing excellent service to our customers."
Henry Schein Animal Health’s expanded offerings include VetLink and Thrive. VetLink is a new e-commerce web site system that enables veterinary surgeons to access the growing internet sector, allowing you to sell anything from pet prescriptions to accessories online, to be delivered to your customers’ homes by Henry Schein Animal Health. Thrive is a new veterinary business analysis service that integrates with practice management software to use a Key Performance Indicator based approach that provides insight into a your practice and identifies areas where you can enhance your business.
Avid has released a new version of it's microchip registration system, which offers a significantly enhanced statistical analysis of the microchipping done at your practice.
The new MicroChip Plus section of the site is specifically for implanters, and contains the following:
Avid says the registration system, which has built-in postcode software, can now re-use more registration details, so that registering a complete litter will take less time. This is especially important when microchips are being registered for or by breeders.
Denise Chaloner, Manager at Avid said: “Avid MicroChip Plus gives our customers more control of how they manage pet microchipping within their organisation. Listening to feedback has inspired Avid to develop a more tailor-made and efficient system for the end user, also enabling the generation of reports, statistics and targets”.
Customers with supporting practice management systems may register microchips directly from their software using VetXML and VetEnvoy.
For more information contact Avid on freephone 0800 652 7 977 or email sales@avidplc.com
Nutricat, a supermarket cat food launched this year, has released the results of a survey which, it says, shows that modern day lifestyles are resulting in British cat owners anthropomorphising their cats.
The survey found that 54% of cat owners believe their cat shares similar emotions to them, 40% sign greetings cards from their cat, and 1/3 say their cat is a better listener than their partner.
Anthropomorphism is nothing new, and since the press release came from a supermarket brand, it would ordinarily have been destined for the 'Deleted Items' folder.
However, one thing caught my eye. In the press release, Nutricat was described as: a new brand of veterinarian approved advanced feline nutrition'.
But it's not just how Nutricat is described in the press release. The title of the Nutricat website is: 'Veterinarian approved cat food', and the words 'veterinarian approved' appear no less than 3 times on the home page. It doesn't stop there. Tesco seems to have got the message too.
So how many veterinary surgeons are required to endorse something in order to claim, reasonably, that it is 'veterinarian approved'. A couple of RCVS Specialists in Feline Medicine? 10 general practitioners? 20? 50? 100?
VetSurgeon.org rang the PR agency for Nutricat and asked the question.
The answer is one.
What do you think? Take part in our poll, here: http://www.vetsurgeon.org/forums/t/9928.aspx
The British Veterinary Association has welcomed the European Commission's Action Plan on Antimicrobial resistance (AMR), launched yesterday on the eve of European Antibiotic Awareness Day.
The Action Plan sets out 12 actions:
However, the association has expressed concern that the Commission has given only qualified support for new antimicrobials for veterinary use. Carl Padgett, President of the BVA, said: "There is much to be applauded in this action plan. In particular the BVA supports the calls for more and better coordinated research, more responsible use of antimicrobials in human and veterinary medicine, and the development of diagnostic tools to quickly and accurately identify the right drug for the right bug.
"The use of antimicrobials in the treatment and control of animal diseases is essential and the BVA supports the strong messages in this plan. Any option for managing AMR must be firmly rooted in sound scientific assessment of the risk.
"While the report recognises the difficulties that have led to the hampering of research into new antimicrobials for veterinary use, we are concerned that there is only qualified support from the Commission for the development of these new medicines for animal use.
"Research into new antimicrobials should be supported in both human and veterinary medicine. We need to ensure the creation of a more predictable regulatory environment to encourage new products for animals to be brought to the market.
"Finally, while the BVA supports the need for a new regulatory framework any new regulations must not impede the ability of veterinary surgeons to prescribe and dispense medicines according to their clinical judgement."
Meanwhile, Jill Moss of the Bella Moss Foundation added her voice to those calling for responsible use of antibiotics, highlighting recent research from the Royal Veterinary College that has established a clear link between pets with MRSA infection and human hospital-associated MRSA. What is less widely recognised, she says, is that resistant bacteria can be passed from human to animal.
The charity is now calling on health and veterinary professionals to work together to achieve a reduction in resistant infections by raising awareness and promoting the responsible use of antibiotics.
The Royal College of Veterinary Surgeons is calling for comment on a draft Performance Protocol, which aims to manage proportionately any justified concerns about the professional performance of veterinary surgeons and registered veterinary nurses.
The RCVS's Preliminary Investigation and Advisory Committees have been working together to develop a new protocol setting out the way in which the College will respond to ongoing performance-related concerns. There is an expectation that veterinary surgeons and RVNs are already regularly reviewing their clinical work in the workplace. This will be reinforced by the new principles-based Code of Professional Conduct, currently being finalised, which is likely to require clinical governance to be part of professional practice for veterinary surgeons and RVNs.
According to the College, the draft protocol is intended to formalise and build on the way it already manages ongoing serious performance-related concerns. It introduces new measures, including supervision and undertakings, to seek to ensure that veterinary surgeons and RVNs take reasonable steps to address any serious performance concerns. This will bring the RCVS into line with other professional regulators and enable a tailored and proportionate response to these cases to protect the welfare of animals and the public interest. The College's current system of offering advice to veterinary surgeons and RVNs will remain for complaints which are closed, because there is no indication of serious professional misconduct.
The College says that according to independent legal advice, such an approach is appropriate and necessary in order for it to fulfil its regulatory responsibilities. The draft performance protocol follows similar legal advice that supported the implementation of the RCVS Health Protocol, and both protocols clarify the College's parallel jurisdiction relating to health and performance-related issues.
RCVS President Jerry Davies said: "When veterinary surgeons and registered veterinary nurses are unable to deal with performance-related concerns, it is important that we are able to provide a supportive framework to oversee remedial steps that are designed to address those concerns and encourage professional development. This is best achieved outside a Disciplinary Committee hearing, if at all possible".
The approved draft protocol is now open for public consultation, and may be found at www.rcvs.org.uk/performance. All comments on the draft should be emailed to Simon Wiklund, Advisory Manager at s.wiklund@rcvs.org.uk by 13 January 2012, with 'Performance Protocol' added to the subject heading.
The feedback received from the consultation will be considered by the Preliminary Investigation and Advisory Committees in January 2012, before being submitted to RCVS Council for approval in March.
The College says it hopes that a performance protocol will form part of the supporting guidance to the new RCVS Codes of Professional Conduct for both veterinary surgeons and registered veterinary nurses.